Diagnosis of active tuberculosis disease: From microscopy to molecular techniques

Journal of Clinical Tuberculosis and Other Mycobacterial Diseases

Volumn 4, Issue , 2016, Pages 33-43

  Caulfield, Adam J ^a   Wengenack, Nancy L ^a  

^a MAYO CLINIC   (United States)

Author keywords

Acid fast staining; GeneXpert MTB RIF assay; MALDI TOF; Sequencing; Sputum processing; Tuberculosis culture

Indexed keywords

EID: 84973299862     PISSN: None     EISSN: 24055794     Source Type: Journal    
DOI: 10.1016/j.jctube.2016.05.005     Document Type: Review

References (85)

1. Global Tuberculosis Report 2015, World Health Organization, Geneva, Switzerland http://www.who.int/tb/publications/global_report/en/. 20th ed.
2. Talbot E.A., Perkins M.D., Silva S.F., Frothingham R. Disseminated bacille Calmette-Guerin disease after vaccination: case report and review. Clin Infect Dis 1997, 24(6):1139-1146.
3. Redelman-Sidi G., Glickman M.S., Bochner B.H. The mechanism of action of BCG therapy for bladder cancer-a current perspective. Nat Rev Urol 2014, 11(3):153-162.
4. Asselineau C., Asselineau J., Laneelle G., Laneelle M.A. The biosynthesis of mycolic acids by mycobacteria: current and alternative hypotheses. Prog Lipid Res 2002, 41(6):501-523.
5. Mahapatra S., Basu J., Brennan P.J., Crick D.C. Structure, biosynthesis, and genetics of the mycolic acid-arabinogalactan-peptidoglycan complex 2005, 275-285. Tuberculosis and the Tubercle Bacillus ASM Press, Washington, DC.
6. Clinical Microbiology Procedures Handbook 2010, American Society for Microbiology, Washington, DC. 3rd ed. L.S. Garcia (Ed.).
7. Baron E.J. Specimen collection, transport, and processing: bacteriology 2015, Manual of Clinical Microbiology, ASM Press, Washington, D.C. 11th ed.
8. Clinical Laboratory Standards Institute (CLSI). Laboratory detection and identification of mycobacteria. Document M48-A. Wayne, PA; 2008.
9. Jensen P.A., Lambert L.A., Iademarco M.F., Ridzon R. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings,. MMWR Recomm Rep 2005, 54(RR-17):1-141.
10. Abraham P.R., Sharma V.D., Shivannavar C.T. Diagnosis of TB from smear & culture negative sputum specimens by IS 6110 based PCR. Indian J Med Res 2012, 135:249-251.
11. Ssengooba W., Kateete D.P., Wajja A., Bugumirwa E., Mboowa G., Namaganda C., et al. An early morning sputum sample is necessary for the diagnosis of pulmonary tuberculosis, even with more sensitive techniques: a prospective cohort study among adolescent TB-suspects in Uganda. Tuberc Res Treat 2012, 2012.
12. Das D., Dwibedi B., Kar S.K. Spot or early morning sample for mycobacterial culture: which?. Int J Tuberc Lung Dis 2014, 18(3):310-311.
13. Saglam L., Akgun M., Aktas E. Usefulness of induced sputum and fibreoptic bronchoscopy specimens in the diagnosis of pulmonary tuberculosis. J Int Med Res 2005, 33(2):260-265.
14. Gonzalez-Angulo Y., Wiysonge C.S., Geldenhuys H., Hanekom W., Mahomed H., Hussey G., et al. Sputum induction for the diagnosis of pulmonary tuberculosis: a systematic review and meta-analysis. Eur J Clin Microbiol Infect Dis 2012, 31(7):1619-1630.
15. Pfyffer G.E. Mycobacterium: general characteristics, laboratory detection, and staining procedures. Manual of Clinical Microbiology 2015, 536-569. ASM Press, Washington, DC. 11th ed.
16. Crump J.A., Tanner D.C., Mirrett S., McKnight C.M., Reller L.B. Controlled comparison of BACTEC 13A, MYCO/F LYTIC, BacT/ALERT MB, and ISOLATOR 10 systems for detection of mycobacteremia. J Clin Microbiol 2003, 41(5):1987-1990.
17. Kirby J.E., Delaney M., Qian Q., Gold H.S. Optimal use of Myco/F lytic and standard BACTEC blood culture bottles for detection of yeast and mycobacteria. Arch Pathol Lab Med 2009, 133(1):93-96.
18. Trifiro S., Bourgault A.M., Lebel F., Rene P. Ghost mycobacteria on Gram stain. J Clin Microbiol 1990, 28(1):146-147.
19. Ziehl F. Zur Färbung des Tuberkelbacillus. Deutsche Med Wochenschr 1882, 33:451.
20. Neelsen F. Ein casuistischer Beitrag zu Lehre von der Tuberkulose. Centralblatt für die medizinischen Wissenschaften 1883, 28:497-501.
21. Fite G.L., Cambre P.J., Turner M.H. Procedure for demonstrating lepra bacilli in paraffin sections. Arch Pathol (Chic) 1947, 43(6):624.
22. Hanscheid T., Ribeiro C.M., Shapiro H.M., Perlmutter N.G. Fluorescence microscopy for tuberculosis diagnosis. Lancet Infect Dis 2007, 7(4):236-237.
23. Kommareddi S., Abramowsky C.R., Swinehart G.L., Hrabak L. Nontuberculous mycobacterial infections: comparison of the fluorescent auramine-O and Ziehl-Neelsen techniques in tissue diagnosis. Hum Pathol 1984, 15(11):1085-1089.
24. Lipsky B.A., Gates J., Tenover F.C., Plorde J.J. Factors affecting the clinical value of microscopy for acid-fast bacilli. Rev Infect Dis 1984, 6(2):214-222.
25. Ipuge Y.A., Rieder H.L., Enarson D.A. The yield of acid-fast bacilli from serial smears in routine microscopy laboratories in rural Tanzania. Trans R Soc Trop Med Hyg 1996, 90(3):258-261.
26. Nelson S.M., Deike M.A., Cartwright C.P. Value of examining multiple sputum specimens in the diagnosis of pulmonary tuberculosis. J Clin Microbiol 1998, 36(2):467-469.
27. Walker D., McNerney R., Mwembo M.K., Foster S., Tihon V., Godfrey-Faussett P. An incremental cost-effectiveness analysis of the first, second and third sputum examination in the diagnosis of pulmonary tuberculosis. Int J Tuberc Lung Dis 2000, 4(3):246-251.
28. Mathew P., Kuo Y.H., Vazirani B., Eng R.H., Weinstein M.P. Are three sputum acid-fast bacillus smears necessary for discontinuing tuberculosis isolation?. J Clin Microbiol 2002, 40(9):3482-3484.
29. Wilmer A., Bryce E., Grant J The role of the third acid-fast bacillus smear in tuberculosis screening for infection control purposes: A controversial topic revisited. Can J Infect Dis Med Microbiol 2011, 22(1):e1-e3.
30. Khogali M., Tayler-Smith K., Zachariah R., et al. Diagnosis of pulmonary tuberculosis in a pastoralist population in Ethiopia: are three sputum specimens needed?. Trop Med Int Health 2013, 18(5):632-635.
31. Rehman S., Iqbal R., Munir M.K., Salam A.A., Saeed S. Incremental yield of submitting three sputum specimens for the diagnosis of pulmonary tuberculosis. Pak J Med Res 2013, 52:35-38.
32. Hassan W.A., Omar A., Khalil S., Al-Qarn A.F. Value of repeated direct smear sputum examination in the diagnosis of pulmonary tuberculosis. Open J Respir Dis 2014, 4:41-47.
33. Mase S.R., Ramsay A., Ng V., Henry M., Hopewell P.C., Cunningham J., et al. Yield of serial sputum specimen examinations in the diagnosis of pulmonary tuberculosis: a systematic review. Int J Tuberc Lung Dis 2007, 11(5):485-495.
34. Reduction of number of smears for diagnosis of pulmonary tuberculosis 2007, World Health Organization, World Health Organization, Geneva, Switzerland, http://www.who.int/tb/laboratory/policy_diagnosis_pulmonary_tb/en/.
35. Taylor Z., Nolan C.M., Blumberg H.M. Controlling tuberculosis in the United States. MMWR Recomm Rep 2005, 54(RR-12):1-81. Recommendations from the American Thoracic Society, CDC, and the Infectious Diseases Society of America.
36. Am J Respir Crit Care Med 2000, 161(4 Pt 1):1376-1395. Diagnostic Standards and Classification of Tuberculosis in Adults and Children.
37. Pfyffer G.E., Welscher H.M., Kissling P., Cieslak C., Casal M.J., Gutierrez J., et al. Comparison of the Mycobacteria Growth Indicator Tube (MGIT) with radiometric and solid culture for recovery of acid-fast bacilli. J Clin Microbiol 1997, 35(2):364-368.
38. Huang T.S., Chen C.S., Lee S.S., Huang W.K., Liu Y.C. Comparison of the BACTEC MGIT 960 and BACTEC 460TB systems for detection of mycobacteria in clinical specimens. Ann Clin Lab Sci 2001, 31(3):279-283.
39. Lee J.J., Suo J., Lin C.B., Wang J.D., Lin T.Y., Tsai Y.C. Comparative evaluation of the BACTEC MGIT 960 system with solid medium for isolation of mycobacteria. Int J Tuberc Lung Dis 2003, 7(6):569-574.
40. Cruciani M., Scarparo C., Malena M., Bosco O., Serpelloni G., Mengoli C Meta-analysis of BACTEC MGIT 960 and BACTEC 460TB, with or without solid media, for detection of mycobacteria. J Clin Microbiol 2004, 42(5):2321-2325.
41. Kent P.T., Kubica G.P. Public health microbiology: a guide for the level iii laboratory. U.S. Dept. of Health and Human Services, Public Health Service, Centers for Disease Control 1985, GA, Atlanta.
42. Realini L., De Ridder K., Hirschel B., Portaels F. Blood and charcoal added to acidified agar media promote the growth of Mycobacterium genavense. Diagnostic Microbiology and Infectious Disease 1999, 34(1):45-50.
43. Robbe-Austerman S., Bravo D.M., Harris B. Comparison of the MGIT 960, BACTEC 460TB and solid media for isolation of Mycobacterium bovis in United States veterinary specimens. BMC Vet Res 2013, 9:74.
44. Simner P.J., Doerr K.A., Steinmetz L.K., Wengenack N.L. Mycobacterium and aerobic actinomycete culture: are two medium types and extended incubation times necessary?. J Clin Microbiol 2016, 54(4):1089-1093.
45. Moreira Ada S., Huf G., Vieira M.A., Costa P.A., Aguiar F., Marsico A.G., et al. Liquid vs solid culture medium to evaluate proportion and time to change in management of suspects of tuberculosis-a pragmatic randomized trial in secondary and tertiary health care units in Brazil. PLoS One 2015, 10(6).
46. Chihota V.N., Grant A.D., Fielding K., Ndibongo B., van Zyl A., Muirhead D., et al. Liquid vs. solid culture for tuberculosis: performance and cost in a resource-constrained setting. Int J Tuberc Lung Dis 2010, 14(8):1024-1031.
47. Somoskovi A., Magyar P. Comparison of the mycobacteria growth indicator tube with MB redox, Lowenstein-Jensen, and Middlebrook 7H11 media for recovery of mycobacteria in clinical specimens. J Clin Microbiol 1999, 37(5):1366-1369.
48. Lu D., Heeren B., Dunne W.M. Comparison of the automated Mycobacteria Growth Indicator Tube System (BACTEC 960/MGIT) with Lowenstein-Jensen medium for recovery of mycobacteria from clinical specimens. Am J Clin Pathol 2002, 118(4):542-545.
49. Srisuwanvilai L.O., Monkongdee P., Podewils L.J., Ngamlert K., Pobkeeree V., Puripokai P., et al. Performance of the BACTEC MGIT 960 compared with solid media for detection of Mycobacterium in Bangkok, Thailand. Diagn Microbiol Infect Dis 2008, 61(4):402-407.
50. Hasan M., Munshi S.K., Momi S.B., Rahman F., Noor R. Evaluation of the effectiveness of BACTEC MGIT 960 for the detection of mycobacteria in Bangladesh. Int J Mycobact 2013, 2:214-219.
51. Whyte T., Hanahoe B., Collins T., Corbett-Feeney G., Cormican M. Evaluation of the BACTEC MGIT 960 and MB BAC/T systems for routine detection of Mycobacterium tuberculosis. J Clin Microbiol 2000, 38(8):3131-3132.
52. Gravet A., Souillard N., Habermacher J., Moser A., Lohmann C., Schmitt F., et al. Culture and susceptibility testing of mycobacteria with VersaTREK. Pathol Biol (Paris) 2011, 59(1):32-38.
53. Falconi F.Q., Suarez L.I., Lopez Mde J., Sancho C.G. Comparison of the VersaTREK system and Lowenstein-Jensen medium for the recovery of mycobacteria from clinical specimens. Scand J Infect Dis 2008, 40(1):49-53.
54. Fuller D.D., Davis T.E., Denys G.A., York M.K. Evaluation of BACTEC MYCO/F Lytic medium for recovery of mycobacteria, fungi, and bacteria from blood. J Clin Microbiol 2001, 39(8):2933-2936.
55. Vetter E., Torgerson C., Feuker A., Hughes J., Harmsen S., Schleck C., et al. Comparison of the BACTEC MYCO/F Lytic bottle to the isolator tube, BACTEC Plus Aerobic F/bottle, and BACTEC Anaerobic Lytic/10 bottle and comparison of the BACTEC Plus Aerobic F/bottle to the Isolator tube for recovery of bacteria, mycobacteria, and fungi from blood. J Clin Microbiol 2001, 39(12):4380-4386.
56. Crump J.A., Morrissey A.B., Ramadhani H.O., Njau B.N., Maro V.P., Reller L.B. Controlled comparison of BacT/Alert MB system, manual Myco/F lytic procedure, and isolator 10 system for diagnosis of Mycobacterium tuberculosis bacteremia. J Clin Microbiol 2011, 49(8):3054-3057.
57. Simner P.J., Stenger S., Richter E., Brown-Elliot B.A., Wallace R.J., Wengenack N.L. Mycobacterium: laboratory characteristics of slowly growing mycobacteria 2015, Manual of Clinical Microbiology, ASM Press, Washington, DC. 11th ed.
58. Lebrun L., Espinasse F., Poveda J.D., Vincent-Levy-Frebault V. Evaluation of nonradioactive DNA probes for identification of mycobacteria. J Clin Microbiol 1992, 30(9):2476-2478.
59. Bull T.J., Shanson D.C. Evaluation of a commercial chemiluminescent gene probe system 'AccuProbe' for the rapid differentiation of mycobacteria, including 'MAIC X', isolated from blood and other sites, from patients with AIDS. J Hosp Infect 1992, 21(2):143-149.
60. Tortoli E., Pecorari M., Fabio G., Messino M., Fabio A. Commercial DNA probes for mycobacteria incorrectly identify a number of less frequently encountered species. J Clin Microbiol 2010, 48(1):307-310.
61. Christiansen D.C., Roberts G.D., Patel R. Mycobacterium celatum, an emerging pathogen and cause of false positive amplified Mycobacterium tuberculosis direct test. Diagn Microbiol Infect Dis 2004, 49(1):19-24.
62. Russo C., Tortoli E., Menichella D. Evaluation of the new GenoType Mycobacterium assay for identification of mycobacterial species. J Clin Microbiol 2006, 44(2):334-339.
63. Tortoli E, Mariottini A, Mazzarelli G Evaluation of INNO-LiPA MYCOBACTERIA v2: improved reverse hybridization multiple DNA probe assay for mycobacterial identification. J Clin Microbiol 2003, 41(9):4418-4420.
64. Machen A., Kobayashi M., Connelly M.R., Wang Y.F. Comparison of heat inactivation and cell disruption protocols for identification of mycobacteria from solid culture media by use of vitek matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol 2013, 51(12):4226-4229.
65. Clark R.B., Lewinski M.A., Loeffelholz M.J., Tibbetts R.J. Cumitech 31A: verification and validation of procedures in the clinical microbiology laboratory 2009, Washington, DC, ASM Press.
66. Lotz A., Ferroni A., Beretti J.L., Dauphin B., Carbonnelle E., Guet-Revillet H., et al. Rapid identification of mycobacterial whole cells in solid and liquid culture media by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol 2010, 48(12):4481-4486.
67. Saleeb P.G., Drake S.K., Murray P.R., Zelazny A.M. Identification of mycobacteria in solid-culture media by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol 2011, 49(5):1790-1794.
68. El Khechine A., Couderc C., Flaudrops C., Raoult D., Drancourt M. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry identification of mycobacteria in routine clinical practice. PLoS One 2011, 6(9):e24720.
69. Mather C.A., Rivera S.F., Butler-Wu S.M. Comparison of the Bruker Biotyper and Vitek MS matrix-assisted laser desorption ionization-time of flight mass spectrometry systems for identification of mycobacteria using simplified protein extraction protocols. J Clin Microbiol 2014, 52(1):130-138.
70. Buckwalter S.P., Olson S.L., Connelly B.J., Lucas B.C., Rodning A.A., Walchak R.C., et al. Evaluation of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of Mycobacterium species, Nocardia species, and other aerobic actinomycetes. J Clin Microbiol 2016, 54(2):376-384.
71. Dhiman N., Hall L., Wohlfiel S.L., Buckwalter S.P., Wengenack N.L. Performance and cost analysis of matrix-assisted laser desorption ionization-time of flight mass spectrometry for routine identification of yeast. J Clin Microbiol 2011, 49(4):1614-1616.
72. Balada-Llasat J.M., Kamboj K., Pancholi P. Identification of mycobacteria from solid and liquid media by matrix-assisted laser desorption ionization-time of flight mass spectrometry in the clinical laboratory. J Clin Microbiol 2013, 51(9):2875-2879.
73. Turenne C.Y., Tschetter L., Wolfe J., Kabani A. Necessity of quality-controlled 16S rRNA gene sequence databases: identifying nontuberculous Mycobacterium species. J Clin Microbiol 2001, 39(10):3637-3648.
74. Updated guidelines for the use of nucleic acid amplification tests in the diagnosis of tuberculosis. MMWR Morb Mortal Wkly Rep 2009, 58(1):7-10. Centers for Disease Control and Prevention (CDC).
75. MMWR Morb Mortal Wkly Rep 2013, 62(41):821-827. Centers for Disease Control and Prevention (CDC).
76. Piersimoni C., Scarparo C. Relevance of commercial amplification methods for direct detection of Mycobacterium tuberculosis complex in clinical samples. J Clin Microbiol 2003, 41(12):5355-5365.
77. Tortoli E., Russo C., Piersimoni C., Mazzola E., Dal Monte P., Pascarella M., et al. Clinical validation of Xpert MTB/RIF for the diagnosis of extrapulmonary tuberculosis. Eur Respir J 2012, 40(2):442-447.
78. Chang K., Lu W., Wang J., Zhang K., Jia S., Li F., et al. Rapid and effective diagnosis of tuberculosis and rifampicin resistance with Xpert MTB/RIF assay: a meta-analysis. J Infect 2012, 64(6):580-588.
79. Food and Drug Administration (FDA). New data shows test can help physicians remove patients with suspected TB from isolation earlier. Press Release. 2015 Feb 12; . [accessed 15.02.15. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm434226.htm.
80. Williamson D.A., Basu I., Bower J., Freeman J.T., Henderson G., Roberts S.A. An evaluation of the Xpert MTB/RIF assay and detection of false-positive rifampicin resistance in Mycobacterium tuberculosis. Diagn Microbiol Infect Dis 2012, 74(2):207-209.
81. Flores L.L., Pai M., J.M.Colford, Riley L.W. In-house nucleic acid amplification tests for the detection of Mycobacterium tuberculosis in sputum specimens: meta-analysis and meta-regression. BMC Microbiol 2005, 5:55.
82. Daum L.T., Rodriguez J.D., Worthy S.A., Ismail N.A., Omar S.V., Dreyer A.W., et al. Next-generation ion torrent sequencing of drug resistance mutations in Mycobacterium tuberculosis strains. J Clin Microbiol 2012, 50(12):3831-3837.
83. Walker T.M., Kohl T.A., Omar S.V., Hedge J., Del Ojo Elias C., Bradley P., et al. Whole-genome sequencing for prediction of Mycobacterium tuberculosis drug susceptibility and resistance: a retrospective cohort study. Lancet Infect Dis 2015, 15(10):1193-1202.
84. Lawn S.D., Kerkhoff A.D., Vogt M., Wood R. Diagnostic accuracy of a low-cost, urine antigen, point-of-care screening assay for HIV-associated pulmonary tuberculosis before antiretroviral therapy: a descriptive study. Lancet Infect Dis 2012, 12(3):201-209.
85. Shah M., Ssengooba W., Armstrong D., Nakiyingi L., Holshouser M., Ellner J.J., et al. Comparative performance of urinary lipoarabinomannan assays and Xpert MTB/RIF in HIV-infected individuals. Aids 2014, 28(9):1307-1314.